Background Cardiogenic shock complicating acute myocardial infarction (AMI) remains the
leading cause of death in patients hospitalized with AMI. Although several studies have …

Objectives. We sought to examine the use, complications and outcomes with early intraaortic
balloon counterpulsation (IABP) in patients presenting with cardiogenic shock complicating …

BACKGROUND: In current guidelines, intraaortic balloon pumping (IABP) is considered a
class 1 indication in cardiogenic shock complicating acute myocardial infarction. However …

We conducted the IABP Cardiogenic Shock Trial (ClinicalTrials. gov ID NCT00469248) as a
prospective, randomized, monocentric clinical trial to determine the hemodynamic effects of …

Background In current international guidelines, intraaortic balloon counterpulsation is
considered to be a class I treatment for cardiogenic shock complicating acute myocardial …

Objectives. We sought to explore the potential benefit of combining intraaortic balloon
counterpulsation (IABP) with thrombolysis for acute myocardial infarction (MI) complicated …

Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump
counterpulsation (IABP) are established treatment modalities in acute myocardial infarction …

The impact of intra-aortic balloon counterpulsation (IABC) on survival of patients with acute
myocardial infarction (AMI) complicated by cardiogenic shock (CS) has been evaluated in …

Background In current international guidelines the recommendation for intra-aortic balloon
pump (IABP) use has been downgraded in cardiogenic shock complicating acute …

Context Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in
patients with cardiogenic shock and reduces infarct size when placed prior to reperfusion in …